When was Hippo Dx founded?

Hippo Dx was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Hippo Dx located?

Hippo Dx is headquartered in Belgium.

How many employees does Hippo Dx have?

As of May 31, 2026, the latest employee count at Hippo Dx is 13.

Is Hippo Dx a funded company?

Hippo Dx is a funded company, having raised a total of $4.67M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2020.

When was the latest funding round of Hippo Dx?

Hippo Dx's latest funding was a $***** Series A round on Oct 04, 2023, with participation from 2 investors. Its primary sector is Immunology. In Belgium, the Immunology sector has seen $128M in funding in 2026 to date.

Where does Hippo Dx rank among its competitors?

Hippo Dx ranks 9th amongst 18 active competitors, of which 7 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Santersus, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Hippo Dx?

Hippo Dx's top competitors include SetPoint Medical, Cel-Sci and Boomerang Medical. Among them, Santersus secured the most recent funding round in December, 2025.

Hippo Dx - 2026 Company Profile, Team, Funding, Competitors & Financials

Hippo Dx is a series A company based in Belgium, founded in 2020 by Peter Deroovere and Wim Hofkens. It operates as a Developer of a medical device to provide an automated test that detects allergies. Hippo Dx has raised $4.67M in funding from LRM and AllerFund. The company has 18 active competitors, including 7 funded and 2 that have exited. Its top competitors include companies like SetPoint Medical, Cel-Sci and Boomerang Medical.

Company Details

Developer of a medical device to provide an automated test that detects allergies. It offers S.P.A.T. that assists doctors and medical personnel in the diagnosis and treatment of chronic conditions and pathologies based on robotics and artificial intelligence technologies.

Website: hippo-dx.com
Social
Email ID: *****@hippo-dx.com

Key Metrics

Founded Year

2020

Location

Belgium

Stage

Series A

Total Funding

$4.67M in 2 rounds

Latest Funding Round

Series A, Oct 04, 2023, $*****

Investors

LRM & 2 more

Ranked

9^th among 18 active competitors

Employee Count

13 as on May 31, 2026

Similar Companies

SetPoint Medical & 19 more

View Hippo Dx's full profile

Hippo Dx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Hippocreates CIN: 0748.949.371 , Belgium, Active	Jun 24, 2020	-	6 (As on Dec 31, 2022)	-

Hippo Dx has raised a total funding of $4.67M over 2 rounds. Its first funding round was on 2020. Its latest funding round was a Series A round on Oct 04, 2023 for $*****. 2 investors participated in its latest round. Hippo Dx has 3 institutional investors.

Here is the list of recent funding rounds of Hippo Dx:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 04, 2023	8971010	Series A	8249223	4604798	6521769	3383797
2020	9947	Seed	6638	9175	5065	imec.istart

Access funding benchmarks and valuations. Sign up today!

View details of Hippo Dx's funding rounds and investors

The founders of Hippo Dx are Peter Deroovere and Wim Hofkens.

Here are the details of Hippo Dx's key team members:

Peter Deroovere: Co-Founder of Hippo Dx.
Contact Info: 1 email address
Wim Hofkens: Co-Founder of Hippo Dx.
Contact Info: 1 email address

View details of Hippo Dx's Founder profiles and Board Members

Hippo Dx's employee count trend

Hippo Dx has 13 employees as of May 26. Here is Hippo Dx's employee count trend over the years:

Uncover Hippo Dx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Hippo Dx include SetPoint Medical, Cel-Sci and Boomerang Medical. Here is the list of Top 10 competitors of Hippo Dx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SetPoint Medical 2006, Santa Clarita (United States), Series F	Developer of implantable neuromodulation devices for inflammatory diseases	$388M	Norwest, Medtronic & 32 others	64/100
2nd	Cel-Sci 1983, Vienna (United States), Public	Developer of immunotherapy products for the treatment of cancer and infectious diseases	-	Alpha Capital Partners, Midsummer Capital ... & 7 others	53/100
3rd	Boomerang Medical 2021, Mountain View (United States), Series B	Bioelectronic device technology for the treatment of autoimmune diseases	$35M	Arboretum Ventures, Hatteras Venture Partners	52/100
4th	Impulse Biomedical 2018, Cape Town (South Africa), Seed	Developer of a device for adrenaline auto-injection	-	Futuregrowth, Launch Africa & 2 others	44/100
5th	Ablatus Therapeutics 2015, Cambridge (United Kingdom), Deadpooled	Developer of a device for bimodal electric tissue ablation	$5.72M	NVM, Turquoise & 23 others	39/100
6th	RegenLab 2003, Brooklyn (United States), Funding Raised	Provider of medical devices to develop cellular therapies	-	-	38/100
7th	Santersus 2019, Maur (Switzerland), Series A	Developer of blood purification device used in sepsis, autoimmune diseases, cancer and Covid-19	-	Norcliffe Capital, Terumo Medical	38/100
8th	INIA Biosciences 2020, Boston (United States), Funding Raised	Developer of diagnostic devices to treat inflammatory diseases	-	National Science Foundation, BioInnovation Institute ... Read more	37/100
9th	Hippo Dx 2020, Belgium, Series A	Developer of a medical device to provide an automated test that detects allergies	$4.67M	LRM, imec.istart & 1 others	35/100
10th	Labseed 2009, Lausanne (Switzerland), Seed	Developer of technology to suppress capsular contraction	$115K	Venture Kick, Venturelab	28/100